{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:41:19Z","timestamp":1785404479447,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Cancer Center Support Grant","award":["NCI Grant P30 CA016672"],"award-info":[{"award-number":["NCI Grant P30 CA016672"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12022-019-09592-3","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T17:01:32Z","timestamp":1573923692000},"page":"285-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-7072","authenticated-orcid":false,"given":"Angelica M.","family":"Silva-Figueroa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Roland","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Christakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callisia N.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naifa L.","family":"Busaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,16]]},"reference":[{"issue":"2","key":"9592_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"GG Fernandez-Ranvier","year":"2009","unstructured":"G. G. Fernandez-Ranvier et al., \u201cDefining a molecular phenotype for benign and malignant parathyroid tumors,\u201d Cancer, vol. 115, no. 2, pp. 334-344, Jan 15 2009, https:\/\/doi.org\/10.1002\/cncr.24037.","journal-title":"Cancer"},{"issue":"6","key":"9592_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.hoc.2012.08.009","volume":"26","author":"A Mohebati","year":"2012","unstructured":"A. Mohebati, A. Shaha, and J. Shah, \u201cParathyroid carcinoma: challenges in diagnosis and treatment,\u201d Hematology\/oncology clinics of North America, vol. 26, no. 6, pp. 1221-1238, Dec 2012, https:\/\/doi.org\/10.1016\/j.hoc.2012.08.009.","journal-title":"Hematology\/oncology clinics of North America"},{"issue":"Suppl 1","key":"9592_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5146\/tjpath.2015.01316","volume":"31","author":"K Duan","year":"2015","unstructured":"K. Duan and O. Mete, \u201cParathyroid Carcinoma: Diagnosis and Clinical Implications,\u201d Turk Patoloji Derg, vol. 31 Suppl 1, pp. 80-97, 2015, https:\/\/doi.org\/10.5146\/tjpath.2015.01316.","journal-title":"Turk Patoloji Derg"},{"key":"9592_CR4","unstructured":"R. A. DeLellis, C. Larsson, A. Arnold, R. Lloy, J. Bilezikian, and O. Mete, \u201cTumors of the parathyroid glands,\u201d in In WHO Classification of Tumors of Endocrine Organs, R. R Lloyd, Osamura, G., Kloppel & J Rosai. Ed. Lyon, France: IARC Press, 2017, pp. pp 145\u2013159."},{"issue":"2","key":"9592_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/cncr.22790","volume":"110","author":"GG Fernandez-Ranvier","year":"2007","unstructured":"G. G. Fernandez-Ranvier et al., \u201cParathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?,\u201d Cancer, vol. 110, no. 2, pp. 255-264, Jul 15 2007, https:\/\/doi.org\/10.1002\/cncr.22790.","journal-title":"Cancer"},{"issue":"12","key":"9592_CR6","first-page":"541","volume":"24","author":"J Chen","year":"2010","unstructured":"J. Chen, J. Liu, and J. Wang, \u201c[Diagnosis and surgical treatment of parathyroid carcinoma],\u201d Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, vol. 24, no. 12, pp. 541-544, Jun 2010.","journal-title":"Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery"},{"issue":"9","key":"9592_CR7","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1245\/s10434-016-5248-6","volume":"23","author":"I Christakis","year":"2016","unstructured":"I. Christakis, N. Bussaidy, C. Clarke, L. J. Kwatampora, C. L. Warneke, A. M. Silva, M. D. Williams, E. G. Grubbs, J. E. Lee, N. D. Perrier, \u201cDifferentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer (in English),\u201d Annals of surgical oncology, vol. 23, no. 9, pp. 2889-2897, Sep 2016, https:\/\/doi.org\/10.1245\/s10434-016-5248-6.","journal-title":"Annals of surgical oncology"},{"issue":"4","key":"9592_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0002-9610(85)80050-7","volume":"149","author":"CA Wang","year":"1985","unstructured":"C. A. Wang and R. D. Gaz, \u201cNatural history of parathyroid carcinoma. Diagnosis, treatment, and results,\u201d American journal of surgery, vol. 149, no. 4, pp. 522-527, Apr 1985.","journal-title":"American journal of surgery"},{"issue":"4","key":"9592_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12022-008-9050-2","volume":"19","author":"RA Delellis","year":"2008","unstructured":"R. A. Delellis, \u201cChallenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma,\u201d Endocr Pathol, vol. 19, no. 4, pp. 221-225, Winter 2008, https:\/\/doi.org\/10.1007\/s12022-008-9050-2.","journal-title":"Endocr Pathol"},{"issue":"10","key":"9592_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/jclinpath-2015-203186","volume":"68","author":"Kai Duan","year":"2015","unstructured":"K. Duan, K. Gomez Hernandez, and O. Mete, \u201cClinicopathological correlates of hyperparathyroidism,\u201d J Clin Pathol, Jul 10 2015, https:\/\/doi.org\/10.1136\/jclinpath-2015-203186.","journal-title":"Journal of Clinical Pathology"},{"issue":"2","key":"9592_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","volume":"29","author":"LA Erickson","year":"2018","unstructured":"L. A. Erickson and O. Mete, \u201cImmunohistochemistry in Diagnostic Parathyroid Pathology,\u201d Endocr Pathol, vol. 29, no. 2, pp. 113-129, Jun 2018, https:\/\/doi.org\/10.1007\/s12022-018-9527-6.","journal-title":"Endocr Pathol"},{"issue":"2","key":"9592_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"C. C. Juhlin et al., \u201cParafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification,\u201d Endocr Relat Cancer, vol. 14, no. 2, pp. 501-512, Jun 2007, https:\/\/doi.org\/10.1677\/ERC-07-0021.","journal-title":"Endocr Relat Cancer"},{"issue":"16","key":"9592_CR13","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.3760\/cma.j.issn.0366-6999.2012.16.018","volume":"125","author":"O Wang","year":"2012","unstructured":"O. Wang et al., \u201cExpression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors (in English), Chinese Medical Journal, vol. 125, no. 16, pp. 2895-2901, Aug 20 2012, https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.2012.16.018.","journal-title":"Chinese Medical Journal"},{"issue":"6","key":"9592_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","volume":"35","author":"V Guarnieri","year":"2012","unstructured":"V. Guarnieri et al., \u201cCDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort,\u201d Cell Oncol (Dordr), vol. 35, no. 6, pp. 411-422, Dec 2012, https:\/\/doi.org\/10.1007\/s13402-012-0100-x.","journal-title":"Cell Oncol (Dordr)"},{"issue":"11","key":"9592_CR15","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","volume":"38","author":"PP Truran","year":"2014","unstructured":"P. P. Truran, S. J. Johnson, R. D. Bliss, T. W. Lennard, and S. R. Aspinall, \u201cParafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer,\u201d World J Surg, vol. 38, no. 11, pp. 2845-2854, Nov 2014, https:\/\/doi.org\/10.1007\/s00268-014-2700-2.","journal-title":"World J Surg"},{"issue":"2","key":"9592_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","volume":"21","author":"Schelto Kruijff","year":"2013","unstructured":"S. Kruijff, S. B. Sidhu, M. S. Sywak, A. J. Gill, and L. W. Delbridge, \u201cNegative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas,\u201d (in English), Annals of Surgical Oncology, vol. 21, no. 2, pp. 426-433, Feb 2014, https:\/\/doi.org\/10.1245\/s10434-013-3288-8.","journal-title":"Annals of Surgical Oncology"},{"issue":"8","key":"9592_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","volume":"32","author":"CC Juhlin","year":"2019","unstructured":"C. C. Juhlin, I.L. Nilsson, K. Lagerstedt-Robinson, A. Stenman, R. Br\u00e4nstr\u00f6m, E. Tham, A. H\u00f6\u00f6g, \u201cParafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center,\u201d Mod Pathol, vol. 32, no. 8, pp. 1082-1094, Jul 2019, https:\/\/doi.org\/10.1038\/s41379-019-0252-6.","journal-title":"Mod Pathol"},{"issue":"6","key":"9592_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.5001\/omj.2015.84","volume":"30","author":"S Karaarslan","year":"2015","unstructured":"S. Karaarslan et al., \u201cThe Role of Parafibromin, Galectin-3, HBME-1, and Ki-67 in the Differential Diagnosis of Parathyroid Tumors,\u201d Oman Med J, vol. 30, no. 6, pp. 421-427, Nov 2015, https:\/\/doi.org\/10.5001\/omj.2015.84.","journal-title":"Oman Med J"},{"issue":"10","key":"9592_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/PAI.0000000000000378","volume":"25","author":"K Hosny Mohammed","year":"2017","unstructured":"K. Hosny Mohammed et al., \u201cParafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas,\u2019 Appl Immunohistochem Mol Morphol, vol. 25, no. 10, pp. 731-735, Nov\/Dec 2017, https:\/\/doi.org\/10.1097\/PAI.0000000000000378.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"9592_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"V. M. Howell et al., \u201cAccuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma,\u201d The Journal of clinical endocrinology and metabolism, vol. 94, no. 2, pp. 434-441, Feb 2009, https:\/\/doi.org\/10.1210\/jc.2008-1740.","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"2","key":"9592_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12022-016-9426-7","volume":"27","author":"N Kumari","year":"2016","unstructured":"N. Kumari, N. Chaudhary, R. Pradhan, A. Agarwal, and N. Krishnani, \u201cRole of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms,\u201d Endocr Pathol, vol. 27, no. 2, pp. 87-96, Jun 2016, https:\/\/doi.org\/10.1007\/s12022-016-9426-7.","journal-title":"Endocr Pathol"},{"issue":"8","key":"9592_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.humpath.2005.06.020","volume":"36","author":"N Bergero","year":"2005","unstructured":"N. Bergero et al., \u201cGalectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases,\u201d Hum Pathol, vol. 36, no. 8, pp. 908-914, Aug 2005, https:\/\/doi.org\/10.1016\/j.humpath.2005.06.020.","journal-title":"Hum Pathol"},{"issue":"2A","key":"9592_CR23","first-page":"1305","volume":"26","author":"F Lumachi","year":"2006","unstructured":"F. Lumachi et al., \u201cPCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma,\u201d Anticancer Res, vol. 26, no. 2A, pp. 1305-1308, Mar-Apr 2006.","journal-title":"Anticancer Res"},{"issue":"11","key":"9592_CR24","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJM199403173301105","volume":"330","author":"VL Cryns","year":"1994","unstructured":"V. L. Cryns et al., \u201cLoss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma,\u201d N Engl J Med, vol. 330, no. 11, pp. 757-761, Mar 17 1994, https:\/\/doi.org\/10.1056\/NEJM199403173301105.","journal-title":"N Engl J Med"},{"issue":"4","key":"9592_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12022-012-9222-y","volume":"23","author":"BM Erovic","year":"2012","unstructured":"B. M. Erovic, L. Harris, M. Jamali, D. P. Goldstein, J. C. Irish, S. L. Asa, O. Mete, \u201cBiomarkers of parathyroid carcinoma,\u201d Endocr Pathol, vol. 23, no. 4, pp. 221-231, Dec 2012, https:\/\/doi.org\/10.1007\/s12022-012-9222-y.","journal-title":"Endocr Pathol"},{"issue":"4","key":"9592_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/EJE-08-0662","volume":"160","author":"V Fendrich","year":"2009","unstructured":"V. Fendrich et al., \u201cUnique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasia,\u201d Eur J Endocrinol, vol. 160, no. 4, pp. 695-703, Apr 2009, https:\/\/doi.org\/10.1530\/EJE-08-0662.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"9592_CR27","doi-asserted-by":"publisher","first-page":"R441","DOI":"10.1530\/ERC-19-0135","volume":"26","author":"Filomena Cetani","year":"2019","unstructured":"F. Cetani, C. Marcocci, L. Torregrossa, and E. Pardi, \u201cAtypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors,\u2019 Endocr Relat Cancer, May 1 2019, https:\/\/doi.org\/10.1530\/ERC-19-0135.","journal-title":"Endocrine-Related Cancer"},{"issue":"4","key":"9592_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"J. D. Carpten et al., \u201cHRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome,\u201d Nat Genet, vol. 32, no. 4, pp. 676-680, Dec 2002, https:\/\/doi.org\/10.1038\/ng1048.","journal-title":"Nat Genet"},{"issue":"9","key":"9592_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"V. M. Howell et al., \u201cHRPT2 mutations are associated with malignancy in sporadic parathyroid tumours,\u201d J Med Genet, vol. 40, no. 9, pp. 657-663, Sep 2003.","journal-title":"J Med Genet"},{"issue":"18","key":"9592_CR30","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"T. M. Shattuck et al., \u201cSomatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma,\u201d N Engl J Med, vol. 349, no. 18, pp. 1722-1729, Oct 30 2003, https:\/\/doi.org\/10.1056\/NEJMoa031237.","journal-title":"N Engl J Med"},{"issue":"11","key":"9592_CR31","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"F. Cetani et al., \u201cGenetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors,\u201d The Journal of clinical endocrinology and metabolism, vol. 89, no. 11, pp. 5583-5591, Nov 2004, https:\/\/doi.org\/10.1210\/jc.2004-0294.","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"9592_CR32","doi-asserted-by":"publisher","unstructured":"A. J. Gill et al., \u201cLoss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias,\u201d Am J Surg Pathol, vol. 30, no. 9, pp. 1140-9, Sep 2006, https:\/\/doi.org\/10.1097\/01.pas.0000209827.39477.4f.","DOI":"10.1097\/01.pas.0000209827.39477.4f"},{"issue":"3","key":"9592_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","volume":"67","author":"CJ Haven","year":"2007","unstructured":"C. J. Haven et al., \u201cIdentification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas,\u201d Clinical endocrinology, vol. 67, no. 3, pp. 370-376, Sep 2007, https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02894.x.","journal-title":"Clinical endocrinology"},{"issue":"5","key":"9592_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"F. Cetani et al., \u201dShould parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? (in English), European journal of endocrinology\/European Federation of Endocrine Societies, vol. 156, no. 5, pp. 547-554, 2007.","journal-title":"European journal of endocrinology\/European Federation of Endocrine Societies"},{"issue":"4","key":"9592_CR35","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1172\/JCI114575","volume":"85","author":"WF Benedict","year":"1990","unstructured":"W. F. Benedict, H. J. Xu, S. X. Hu, and R. Takahashi, \u201cRole of the retinoblastoma gene in the initiation and progression of human cancer,\u201d J Clin Invest, vol. 85, no. 4, pp. 988-993, Apr 1990, https:\/\/doi.org\/10.1172\/JCI114575.","journal-title":"J Clin Invest"},{"issue":"2","key":"9592_CR36","first-page":"223","volume":"10","author":"A Giordano","year":"1996","unstructured":"A. Giordano and H. E. Kaiser, \u201cThe retinoblastoma gene: Its role in cell cycle and cancer (in English),\u201d In Vivo, vol. 10, no. 2, pp. 223-227, Mar-Apr 1996.","journal-title":"In Vivo"},{"issue":"12","key":"9592_CR37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nrc950","volume":"2","author":"M Classon","year":"2002","unstructured":"M. Classon and E. Harlow, \u201cThe retinoblastoma tumour suppressor in development and cancer (in English),\u201d Nature Reviews Cancer, vol. 2, no. 12, pp. 910-917, Dec 2002, https:\/\/doi.org\/10.1038\/nrc950.","journal-title":"Nature Reviews Cancer"},{"issue":"11","key":"9592_CR38","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1200\/JCO.1997.15.11.3301","volume":"15","author":"WR Sellers","year":"1997","unstructured":"W. R. Sellers and W. G. Kaelin, \u201cRole of the retinoblastoma protein in the pathogenesis of human cancer (in English),\u201d Journal of Clinical Oncology, vol. 15, no. 11, pp. 3301-3312, Nov 1997.","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"9592_CR39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1445-2197.1995.tb00542.x","volume":"65","author":"P Subramaniam","year":"1995","unstructured":"P. Subramaniam, S. Wilkinson, and J. J. Shepherd, \u201cInactivation of retinoblastoma gene in malignant parathyroid growths: a candidate genetic trigger?,\u201d Aust N Z J Surg, vol. 65, no. 10, pp. 714-716, Oct 1995.","journal-title":"Aust N Z J Surg"},{"issue":"1","key":"9592_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0304-419x(94)90003-5","volume":"1198","author":"W Birchmeier","year":"1994","unstructured":"W. Birchmeier and J. Behrens, \u201cCadherin Expression in Carcinomas - Role in the Formation of Cell-Junctions and the Prevention of Invasiveness (in English), Bba-Rev Cancer, vol. 1198, no. 1, pp. 11-26, May 27 1994, https:\/\/doi.org\/10.1016\/0304-419x(94)90003-5.","journal-title":"Bba-Rev Cancer"},{"issue":"10","key":"9592_CR41","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s00268-015-3149-7","volume":"39","author":"Ralph Schneider","year":"2015","unstructured":"R. Schneider, S. Bartsch-Herzog, A. Ramaswamy, D. K. Bartsch, and E. Karakas, \u201cImmunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma,\u201d World journal of surgery, Jul 8 2015, https:\/\/doi.org\/10.1007\/s00268-015-3149-7.","journal-title":"World Journal of Surgery"},{"issue":"3","key":"9592_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"Thomas Scholzen","year":"2000","unstructured":"T. Scholzen and J. Gerdes, \u201cThe Ki-67 protein: From the known and the unknown (in English), J Cell Physiol, vol. 182, no. 3, pp. 311-322, Mar 2000, https:\/\/doi.org\/10.1002\/(Sici)1097-4652(200003)182:3<311::Aid-Jcp1>3.0.Co;2-9.","journal-title":"Journal of Cellular Physiology"},{"issue":"2","key":"9592_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0046-8177(95)90028-4","volume":"26","author":"GC Abbona","year":"1995","unstructured":"G. C. Abbona, M. Papotti, G. Gasparri, and G. Bussolati, \u201cProliferative Activity in Parathyroid Tumors as Detected by Ki-67 Immunostaining (in English), Human Pathology, vol. 26, no. 2, pp. 135-138, Feb 1995, https:\/\/doi.org\/10.1016\/0046-8177(95)90028-4.","journal-title":"Human Pathology"},{"issue":"1","key":"9592_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/hupa.2003.55","volume":"34","author":"A Stojadinovic","year":"2003","unstructured":"A. Stojadinovic et al., \u201cParathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis,\u201d Hum Pathol, vol. 34, no. 1, pp. 54-64, Jan 2003, https:\/\/doi.org\/10.1053\/hupa.2003.55.","journal-title":"Hum Pathol"},{"issue":"3","key":"9592_CR45","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12253-011-9483-7","volume":"18","author":"K Arvai","year":"2012","unstructured":"K. Arvai et al., \u201cMolecular profiling of parathyroid hyperplasia, adenoma and carcinoma,\u201d Pathology oncology research : POR, vol. 18, no. 3, pp. 607-614, Jul 2012, https:\/\/doi.org\/10.1007\/s12253-011-9483-7.","journal-title":"Pathology oncology research : POR"},{"issue":"4","key":"9592_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ijc.23354","volume":"123","author":"Y Tokumaru","year":"2008","unstructured":"Y. Tokumaru et al., \u201cThe role of PGP9.5 as a tumor suppressor gene in human cancer (in English), Int J Cancer, vol. 123, no. 4, pp. 753-759, Aug 15 2008, https:\/\/doi.org\/10.1002\/ijc.23354.","journal-title":"Int J Cancer"},{"key":"9592_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev.genet.30.1.405","volume":"30","author":"M Hochstrasser","year":"1996","unstructured":"M. Hochstrasser, \u201cUbiquitin-dependent protein degradation (in English), Annu Rev Genet, vol. 30, pp. 405-439, 1996, https:\/\/doi.org\/10.1146\/annurev.genet.30.1.405.","journal-title":"Annu Rev Genet"},{"issue":"3","key":"9592_CR48","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00268-015-3380-2","volume":"40","author":"A Agarwal","year":"2016","unstructured":"A. Agarwal, R. Pradhan, N. Kumari, N. Krishnani, P. Shukla, S. K. Gupta, G. Chand, A. Mishra, G. Agarwal, A. K. Verma, S. K. Mishra, \u201cMolecular Characteristics of Large Parathyroid Adenomas,\u201d World journal of surgery, vol. 40, no. 3, pp. 607-614, Mar 2016, https:\/\/doi.org\/10.1007\/s00268-015-3380-2.","journal-title":"World journal of surgery"},{"issue":"1","key":"9592_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrc1527","volume":"5","author":"FT Liu","year":"2005","unstructured":"F. T. Liu and G. A. Rabinovich, \u201cGalectins as modulators of tumour progression (in English),\u201d Nature Reviews Cancer, vol. 5, no. 1, pp. 29-41, Jan 2005, https:\/\/doi.org\/10.1038\/nrc1527.","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"9592_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1309\/9NXP-7FRF-87MU-2PCK","volume":"126","author":"E Saggiorato","year":"2006","unstructured":"E. Saggiorato et al., \u201cGalectin-3 and Ki-67 expression in multiglandular parathyroid lesions,\u201d Am J Clin Pathol, vol. 126, no. 1, pp. 59-66, Jul 2006, https:\/\/doi.org\/10.1309\/9NXP-7FRF-87MU-2PCK.","journal-title":"Am J Clin Pathol"},{"key":"9592_CR51","first-page":"S63","volume":"33","author":"G Ippolito","year":"2007","unstructured":"G. Ippolito, F. Sebag, F. Palazzo, E. Trichet, C. De Micco, and J. F. Henry, \u201cParathyroid cancer and atypical adenoma: operational diagnosis and surgical treatment (in French), Diabetes Metab, vol. 33, pp. S63-S63, Mar 2007.","journal-title":"Diabetes Metab"},{"issue":"4","key":"9592_CR52","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.surg.2015.06.022","volume":"158","author":"KL Mccoy","year":"2015","unstructured":"K. L. Mccoy et al., \u201cThe clinical importance of parathyroid atypia: Is long-term surveillance necessary? (in English),\u201d Surgery, vol. 158, no. 4, pp. 929-935, Oct 2015, https:\/\/doi.org\/10.1016\/j.surg.2015.06.022.","journal-title":"Surgery"},{"issue":"6","key":"9592_CR53","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","volume":"39","author":"F. Cetani","year":"2016","unstructured":"F. Cetani, E. Pardi, and C. Marcocci, \u201cUpdate on parathyroid carcinoma,\u201d Journal of endocrinological investigation, Mar 21 2016, https:\/\/doi.org\/10.1007\/s40618-016-0447-3.","journal-title":"Journal of Endocrinological Investigation"},{"issue":"5","key":"9592_CR54","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jamcollsurg.2017.01.060","volume":"224","author":"Angelica M. Silva-Figueroa","year":"2017","unstructured":"A. M. Silva-Figueroa et al., \u201cPrognostic Scoring System to Risk Stratify Parathyroid Carcinoma,\u201d J Am Coll Surg, Mar 15 2017, https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.01.060.","journal-title":"Journal of the American College of Surgeons"},{"issue":"1","key":"9592_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","volume":"43","author":"AJ Gill","year":"2019","unstructured":"A. J. Gill et al., \u201cParafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features,\u201d Am J Surg Pathol, vol. 43, no. 1, pp. 35-46, Jan 2019, https:\/\/doi.org\/10.1097\/PAS.0000000000001017.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"9592_CR56","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","volume":"54","author":"Ya Hu","year":"2016","unstructured":"Y. Hu, Q. Liao, S. Cao, X. Gao, and Y. Zhao, \u201cDiagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis,\u201d Endocrine, Jun 1 2016, https:\/\/doi.org\/10.1007\/s12020-016-0997-3.","journal-title":"Endocrine"},{"issue":"1","key":"9592_CR57","first-page":"143","volume":"15","author":"M Nakamura","year":"1999","unstructured":"M. Nakamura et al., \u201cInvolvement of galectin-3 expression in colorectal cancer progression and metastasis,\u201d Int J Oncol, vol. 15, no. 1, pp. 143-148, Jul 1999.","journal-title":"Int J Oncol"},{"issue":"4","key":"9592_CR58","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1053\/hp.2000.6534","volume":"31","author":"K Kawachi","year":"2000","unstructured":"K. Kawachi et al., \u201cGalectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation,\u201d Hum Pathol, vol. 31, no. 4, pp. 428-433, Apr 2000, https:\/\/doi.org\/10.1053\/hp.2000.6534.","journal-title":"Hum Pathol"},{"issue":"1","key":"9592_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2265.2004.01954.x","volume":"60","author":"F Cetani","year":"2004","unstructured":"F. Cetani et al., \u201cA reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer,\u201d Clin Endocrinol (Oxf), vol. 60, no. 1, pp. 99-106, Jan 2004.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-019-09592-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-019-09592-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-019-09592-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:25:51Z","timestamp":1605399951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-019-09592-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,16]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9592"],"URL":"https:\/\/doi.org\/10.1007\/s12022-019-09592-3","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,16]]},"assertion":[{"value":"16 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}